You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ADCY5 mutation

Showing 1 - 25 of 5,515
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ADCY5-related Dyskinesia Trial (caffeinated coffee - decaffeinated coffee)

Not yet recruiting
  • ADCY5-related Dyskinesia
  • caffeinated coffee - decaffeinated coffee
  • (no location specified)
Nov 26, 2021

C677T Methylenetetrahydrofolate Reductase Mutation

Completed
  • Mutation
  • infertily evaluation
  • (no location specified)
May 16, 2023

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Stratification of Overlap Syndrome Phenotype in E1784K Mutation

Recruiting
  • Long QT Syndrome
  • +3 more
    • Saint-Pierre, France, Réunion
      CHU de La Réunion
    Oct 19, 2022

    Rectal Cancer Trial (PD-1, SCRT, Bevacizumab)

    Not yet recruiting
    • Rectal Cancer
    • (no location specified)
    Dec 6, 2022

    Non-squamous Non-small-cell Lung Cancer, Stage IV NSCLC, ROS1 Gene Rearrangement Trial in Toronto (Crizotinib)

    Recruiting
    • Non-squamous Non-small-cell Lung Cancer
    • +4 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    Pilot Study on Caffeine Efficiency in ADCY5-related Dyskinesia

    Unknown status
    • Dyskinesias
      • (no location specified)
      Apr 15, 2020

      Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

      Active, not recruiting
      • Metastatic Lung Non-Small Cell Carcinoma
      • +5 more
      • Laboratory Biomarker Analysis
      • +3 more
      • New Haven, Connecticut
      • +4 more
      Jan 27, 2023

      People Who Have Genetic Changes and Features of Autism: Simons

      Recruiting
      • 16P11.2 Deletion Syndrome
      • +184 more
        • New York, New York
        • +1 more
        Jan 6, 2023

        Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation Trial in United States (drug, diagnostic test, other)

        Recruiting
        • Pancreas Cancer
        • +4 more
        • New Haven, Connecticut
        • +7 more
        Dec 12, 2022

        Spastic Paraplegia Type 50 Trial in Toronto (MELPIDA)

        Active, not recruiting
        • Spastic Paraplegia Type 50
        • MELPIDA
        • Toronto, Ontario, Canada
          The Hospital for Sick Children
        Oct 5, 2023

        An Imaging Study of FCH-PET-CT in Prostate Cancer andBRCA Gene

        Recruiting
        • Prostate Cancer
        • +2 more
        • MRI pelvis or CT imaging
        • +2 more
        • London, Sutton, Surrey, United Kingdom
          Cancer Genetics Unit, Royal Marsden Hospital
        Mar 30, 2022

        Caffeine Efficacy in ADCY5-related Dyskinesia

        Unknown status
        • ADCY5-related Dyskinesia
        • caffeine and movement disorders
        • (no location specified)
        Jul 8, 2020

        Alport Syndrome Trial in Clayton, Parkville, London (ELX-02)

        Recruiting
        • Alport Syndrome
        • Clayton, Victoria, Australia
        • +3 more
        Dec 19, 2022

        Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,

        Recruiting
        • Acute Myeloid Leukemia in Remission
        • +5 more
        • Houston, Texas
          M D Anderson Cancer Center
        Dec 13, 2022

        Prostate Cancer Trial in Toronto (MS3TMRI / TRUS Guided Biopsy)

        Recruiting
        • Prostate Cancer
        • MS3TMRI / TRUS Guided Biopsy
        • Toronto, Ontario, Canada
          Sunnybrook Odette Cancer Centre
        May 5, 2022

        Acute Myeloid Leukemia, Relapsed Cancer, Refractory Cancer Trial in Edmonton, Toronto (Enasidenib, Venetoclax)

        Active, not recruiting
        • Acute Myeloid Leukemia
        • +3 more
        • Edmonton, Alberta, Canada
        • +1 more
        Jan 31, 2023

        Patogenic Mutation in 5 Genes

        Completed
        • Colorectal Cancer
        • +5 more
        • co-occuring mutation
        • Jakarta, ALL, Indonesia
          Vania Myralda Giamour Marbun
        Jul 21, 2021

        Treatment in Carriers of Rare Germline Mutations

        Recruiting
        • Prostate Cancer
          • Sutton, Surrey, United Kingdom
            Institute of Cancer Research and Royal Marsden Hospital
          Mar 30, 2022

          Accelerated/Blast-phase Myeloproliferative Tumor, Chronic-phase Myelofibrosis, IDH2 Mutation Trial in Canada, United States

          Recruiting
          • Accelerated/Blast-phase Myeloproliferative Neoplasm
          • +2 more
          • Scottsdale, Arizona
          • +10 more
          May 9, 2022

          Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation Trial in Worldwide (BIIB067 (Tofersen), Placebo)

          Recruiting
          • Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation
          • BIIB067 (Tofersen)
          • Placebo
          • Scottsdale, Arizona
          • +28 more
          Oct 27, 2022

          Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston

          Recruiting
          • Anatomic Stage IV Breast Cancer AJCC v8
          • +2 more
          • Houston, Texas
            M D Anderson Cancer Center
          Oct 25, 2022

          Recurrent Acute Myeloid Leukemia Trial in United States (Enasidenib Mesylate, Liposome-encapsulated Daunorubicin-Cytarabine)

          Suspended
          • Recurrent Acute Myeloid Leukemia
          • Enasidenib Mesylate
          • Liposome-encapsulated Daunorubicin-Cytarabine
          • Los Angeles, California
          • +3 more
          Sep 27, 2022

          ALK Gene Mutation, Lung Adenocarcinoma, Immunotherapy Trial in Changsha (Pembrolizumab Combined With Bevacizumab and

          Not yet recruiting
          • ALK Gene Mutation
          • +2 more
          • Pembrolizumab Combined With Bevacizumab and Chemotherapy
          • Changsha, Hunan, China
            Hunan Cancer Hospital
          Jul 14, 2022

          Epilepsy Trial in New York (ataluren, Placebo)

          Completed
          • Epilepsy
          • New York, New York
            New York University School of Medicine
          Sep 7, 2021